Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 98 Records) |
Query Trace: Pancreatic Neoplasms and BRCA1[original query] |
---|
A comprehensive literature review and meta-analysis of the prevalence of pan-cancer BRCA mutations, homologous recombination repair gene mutations, and homologous recombination deficiencies. Environmental and molecular mutagenesis 2022 Jul 63 (6): 308-316. Shao Changxia, Wan Jun, Lam Fred C, Tang Huilin, Marley Andrew R, Song Yiqing, Miller Chelsey, Brown Madeline, Han Jiali, Adeboyeje Gboye |
A Systematic Review and Meta-Analysis on the Prognostic Value of BRCA Mutations, Homologous Recombination Gene Mutations, and Homologous Recombination Deficiencies in Cancer. Journal of oncology 2022 8 2022 5830475. Shao Changxia, Chang Michael S, Lam Fred C, Marley Andrew R, Tang Huilin, Song Yiqing, Miller Chelsey, Brown Madeline, Wan Isabella, Han Jiali, Adeboyeje Gboye |
A Genome-First Approach to Estimate Prevalence of Germline Pathogenic Variants and Risk of Pancreatic Cancer in Select Cancer Susceptibility Genes. Cancers 2022 Jul 14 (13): . Astiazaran-Symonds Esteban, Kim Jung, Haley Jeremy S, Kim Sun Young, Rao H Shanker, Genetics Center Regeneron, Carey David J, Stewart Douglas R, Goldstein Alisa |
A Randomized Study of Olaparib or Placebo in Patients with Surgically Removed Pancreatic Cancer who have a BRCA1, BRCA2 or PALB2 Mutation (The APOLLO Trial). Annals of surgical oncology 2022 6 29 (9): 5375-5376. Teke Martha E, Saif Areeba, Ryan Carrie E, Lux Stephanie C, Hernandez Jonathan M, Reiss Kim |
Core Homologous Recombination Mutations and Improved Survival in Nonpancreatic GI Cancers. American journal of clinical oncology 2022 3 45 (4): 137-141. Tan Elaine, Whiting Junmin, Knepper Todd, Xie Hao, Imanirad Iman, Carballido Estrella, Felder Seth, Frakes Jessica, Mo Qianxing, Permuth Jennifer B, Somerer Katelyn, Kim Richard, Anaya Daniel A, Fleming Jason B, Walko Christine, Sahin Ibrahim |
Comprehensive Analysis of Somatic Reversion Mutations in Homologous Recombination Repair (HRR) Genes in A Large Cohort of Chinese Pan-cancer Patients. Journal of Cancer 2022 3 13 (4): 1119-1129. Zong Hong, Zhang Jian, Xu Zhengyang, Pan Jia-Ni, Wang Rong, Han Jinming, Jiang Miao, Ren Ruiping, Zang Li, Wang Haitao, Cao Wen-Mi |
Reflex Testing for Germline BRCA1, BRCA2, PALB2, and ATM Mutations in Pancreatic Cancer: Mutation Prevalence and Clinical Outcomes From Two Canadian Research Registries. JCO precision oncology 2022 2 2 1-16. Smith Alyssa L, Wong Cavin, Cuggia Adeline, Borgida Ayelet, Holter Spring, Hall Anita, Connor Ashton A, Bascuñana Claire, Asselah Jamil, Bouganim Nathaniel, Poulin Véronique, Jolivet Jacques, Vafiadis Petro, Le Philippe, Martel Guillaume, Lemay Frédéric, Beaudoin Annie, Rafatzand Khashayar, Chaudhury Prosanto, Barkun Jeffrey, Metrakos Peter, Marcus Victoria, Omeroglu Atilla, Chong George, Akbari Mohammad R, Foulkes William D, Gallinger Steven, Zogopoulos Geor |
Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation. Genes 2022 2 13 (2): . Vietri Maria Teresa, D'Elia Giovanna, Caliendo Gemma, Albanese Luisa, Signoriello Giuseppe, Napoli Claudio, Molinari Anna Mar |
NGS-based targeted gene mutational profiles in Korean patients with pancreatic cancer. Scientific reports 2022 12 12 (1): 20937. Jung Kwangrok, Lee Sejoon, Na Hee Young, Kim Ji-Won, Lee Jong-Chan, Hwang Jin-Hyeok, Kim Jin Won, Kim Jaihw |
Case report: olaparib use in metastatic lung adenocarcinoma with BRCA2 pathogenic variant. Cold Spring Harbor molecular case studies 2022 12 8 (7): . Soon Jian Hao Jonathan, Hoai Chan Sock, Weng Daniel Tan Shao, Ngeow Joanne, Chiang Jianba |
BRCA1/2 Reversion Mutations in Patients Treated with Poly ADP-Ribose Polymerase (PARP) Inhibitors or Platinum Agents. Medicina (Kaunas, Lithuania) 2022 12 58 (12): . Darabi Sourat, Braxton David R, Xiu Joanne, Carneiro Benedito A, Swensen Jeff, Antonarakis Emmanuel S, Liu Stephen V, McKay Rana R, Spetzler David, El-Deiry Wafik S, Demeure Michael |
Prevalence of Germline Sequence Variations Among Patients With Pancreatic Cancer in China. JAMA network open 2022 02 5 (2): e2148721. Yin Lingdi, Wei Jishu, Lu Zipeng, Huang Shimeng, Gao Hao, Chen Jianmin, Guo Feng, Tu Min, Xiao Bin, Xi Chunhua, Zhang Kai, Li Qiang, Wu Junli, Gao Wentao, Jiang Kuirong, Yu Jun, Miao |
Screening Practices for Breast and Nonbreast Cancers in High-Risk Mutation Carriers. The Journal of surgical research 2023 7 291 388-395. Alison C Coogan, Lilia G Lunt, Sarah S Keshwani, Olivia Sandhu, Yanyu Zhang, Cristina O'Donoghue, Andrea Madrigra |
The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 After Progression on Rucaparib. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 7 . Timothy J Brown, Arielle Yablonovitch, Jacob E Till, Jennifer Yen, Lesli A Kiedrowski, Ryan Hood, Mark H O'Hara, Ursina Teitelbaum, Thomas B Karasic, Charles Schneider, Erica L Carpenter, Katherine Nathanson, Susan M Domchek, Kim A Rei |
Genomic landscape of pancreatic cancer in the Japanese version of the Cancer Genome Atlas. Annals of gastroenterological surgery 2023 5 7 (3): 491-502. Taisuke Imamura, Ryo Ashida, Keiichi Ohshima, Katsuhiko Uesaka, Teiichi Sugiura, Yukiyasu Okamura, Katsuhisa Ohgi, Sumiko Ohnami, Takeshi Nagashima, Ken Yamaguc |
Analysis of Plasma Circulating Tumor DNA in Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Modified FOLFIRINOX: Clinical Relevance of DNA Damage Repair Gene Alteration Detection. Cancer research and treatment 2023 5 . Dong-Hoon Lim, Hyunseok Yoon, Kyu-Pyo Kim, Baek-Yeol Ryoo, Sang Soo Lee, Do Hyun Park, Tae Jun Song, Dae Wook Hwang, Jae Hoon Lee, Ki Byung Song, Song Cheol Kim, Seung-Mo Hong, Jaewon Hyung, Changhoon Y |
Genomic landscape and clinical features of rare subtypes of pancreatic cancer: analysis with the national database of Japan. Journal of gastroenterology 2023 4 . Sakakida Tomoki, Ishikawa Takeshi, Doi Toshifumi, Morita Ryuichi, Kataoka Seita, Miyake Hayato, Yamaguchi Kanji, Moriguchi Michihisa, Sogame Yoshio, Yasuda Hiroaki, Iwasaku Masahiro, Konishi Hideyuki, Takayama Koichi, Itoh Yoshi |
Prevalence and Risk Factors of Germline Pathogenic Variants in Pancreatic Ductal Adenocarcinoma. Cancer research and treatment 2023 4 . Ryu Kum Hei, Park Sunhwa, Chun Jung Won, Cho Eunhae, Choi Jongmun, Lee Dong-Eun, Shim Hyoeun, Kim Yun-Hee, Han Sung-Sik, Park Sang-Jae, Woo Sang Myung, Kong Sun-You |
Clinical usefulness of NGS multi-gene panel testing in hereditary cancer analysis. Frontiers in genetics 2023 4 14 1060504. Anaclerio Federico, Pilenzi Lucrezia, Dell'Elice Anastasia, Ferrante Rossella, Grossi Simona, Ferlito Luca Maria, Marinelli Camilla, Gildetti Simona, Calabrese Giuseppe, Stuppia Liborio, Antonucci Iva |
Pathogenic genomic alterations in Chinese pancreatic cancer patients and their therapeutical implications. Cancer medicine 2023 3 . Zhao Zhiming, Li Xiaomo, Wang Fei, Xu Yong, Liu Si, Han Quanli, Yang Zhiying, Huang Weiwei, Yin Zhuzeng, Liu Qu, Tan Haidong, Ma Tonghui, Si Shuang, Huang Jia, Yuan Hongling, Li Wei, Liu Ro |
Germline mutations in homologous recombination repair genes among Chinese pancreatic ductal adenocarcinoma patients detected using next-generation sequencing. Molecular genetics & genomic medicine 2023 3 e2170. Jiang Huiqin, Huang Fei, Chen Xinning, Zhang Li, Shen Minna, Pan Baishen, Wang Beili, Guo W |
Prognostic and predictive value of tumoral DNA damage repair protein expression in patients with resected pancreatic cancer. Clinics and research in hepatology and gastroenterology 2023 2 47 (3): 102091. Ceylan Furkan, Guven Deniz Can, Taban Hakan, Aktepe Oktay, Sahin Taha Koray, Kilickap Sadettin, Turker Alev, Hamaloglu Erhan, Karakoc Derya, Isik Aynur, Akyol Aytekin, Yalcin Suayib, Dizdar Om |
A systematic review and meta-analysis of germline BRCA mutations in pancreatic cancer patients identifies global and racial disparities in access to genetic testing. ESMO open 2023 2 8 (2): 100881. Paiella S, Azzolina D, Gregori D, Malleo G, Golan T, Simeone D M, Davis M B, Vacca P G, Crovetto A, Bassi C, Salvia R, Biankin A V, Casolino |
Rate of Pathogenic Germline Variants in Patients With Lung Cancer. JCO precision oncology 2023 11 7 e2300190. Steven Sorscher, Jaclyn LoPiccolo, Brandie Heald, Elaine Chen, Sara L Bristow, Scott T Michalski, Sarah M Nielsen, Alix Lacoste, Emil Keyder, Hayan Lee, Robert L Nussbaum, Renato Martins, Edward D Espl |
Prevalence of BRCA1 and BRCA2 germline variants in an unselected pancreatic cancer patient cohort in Pakistan. Hereditary cancer in clinical practice 2023 11 21 (1): 22. Noor Muhammad, Ayesha Azeem, Shumaila Arif, Humaira Naeemi, Iqra Masood, Usman Hassan, Bushra Ijaz, Faisal Hanif, Aamir Ali Syed, Muhammed Aasim Yusuf, Muhammad Usman Rash |
Clinical characterization of patients with gBRCA1/2 mutation-positive unresectable pancreatic cancer: a multicenter prospective study. Japanese journal of clinical oncology 2023 10 . Tomohiro Kubo, Joji Muramatsu, Yohei Arihara, Ayako Murota, Kazuma Ishikawa, Makoto Yoshida, Hiroyuki Nagashima, Fumito Tamura, Yuki Ikeda, Makoto Usami, Michihiro Ono, Hajime Nakamura, Daichi Watanabe, Takanori Shibata, Kaoru Kasahara, Akihiro Sakurai, Kohichi Taka |
The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants. Cancer 2023 10 . Ido Laish, Menachem Schechter, Alain Dancour, Sari Lieberman, Zohar Levi, Yael Goldberg, Inbal Kedar, Erez Hasnis, Elizabeth Half, Gili Reznick Levi, Lior Katz, Elez D Vainer, Dor Genzel, Maya Aharoni, Rakefet Chen-Shtoyerman, Naim Abu-Freha, Maria Raitses-Gurevich, Talia Golan, Rinat Bernstein-Molho, Merav Ben Yehoyada, Nathan Gluck, Guy Rosn |
Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study. ESMO open 2023 10 8 (6): 102041. S Joris, H Denys, J Collignon, M Rasschaert, D T'Kint de Roodenbeke, F P Duhoux, J-L Canon, S Tejpar, J Mebis, L Decoster, P Aftimos, J De Grè |
Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area. BMC cancer 2024 4 24 (1): 411. Zhiyuan Wu, Qingyun Zhang, Yiting Jin, Xinju Zhang, Yanli Chen, Can Yang, Xuemei Tang, Haowen Jiang, Xiaoyi Wang, Xinli Zhou, Feng Yu, Bing Wang, Ming Gu |
A MALDI-TOF mass spectrometry-based method for detection of copy number variations in BRCA1 and BRCA2 genes. Frontiers in molecular biosciences 2024 1 10 1301652. Hongjun Zhou, Xin He, Jiadong Zhao, Zhu Mei, Xiayan Zhang, Wen Yuan, Hui Do |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: